Jeff marrazzo spark therapeutics
WebSpark Therapeutics, Inc. Type: Subsidiary of Hoffmann-La Roche: Industry: Biotechnology Pharmaceutical: Founded: 2013; 10 years ago () Founders: Katherine A. High Jeffrey … WebFeb 28, 2024 · "A decade ago, I had lunch with [former Spark CEO] Jeff Marrazzo when he was just getting Spark started and he was one of its three employees and I was beginning to plan our innovation...
Jeff marrazzo spark therapeutics
Did you know?
WebSpark Therapeutics Announces Departure of CEO and Founder Jeff Marrazzo; COO Ron Philip Named as Successor Read More Spark Therapeutics Announces Updated Phase … WebDec 17, 2024 · Jeffrey Marrazzo owns about 305,000 units of Spark Therapeutics, Inc common stock. In the last 4 years at Spark Therapeutics, Inc, Jeffrey Marrazzo has sold …
WebMar 5, 2024 · Roche’s gene therapy outfit Spark Therapeutics will get a fresh face April 1 as co-founding CEO Jeffrey Marrazzo steps down. Chief Operating Officer Ron Philip, a 10-year Pfizer veteran who joined Spark in 2024, will be Marrazzo’s successor. The FDA’s approval of retinal disease gene therapy Luxturna is likely to be the biggest part of… WebDec 17, 2024 · Jeff Marrazzo admitted to mixed emotions Tuesday as Roche closed its $4.3 billion acquisition of Spark Therapeutics, the gene therapy company he co-founded and led as CEO for the past...
The company was founded in 2013 by Katherine A. High, Jeffrey Marrazzo, and Steven Altschuler in an effort to commercially develop treatments against haemophilia that High was working on at Children's Hospital of Philadelphia. In January 2015, the company became a public company, trading under the ticker $ONCE via a $161 million initial public offering led by Chief Legal Officer Joseph La Barge.
WebDec 17, 2024 · “Through this significant investment and plans to more than double our physical footprint, we're poised for continued growth as we seek to develop the next generation of genetic medicines as a member of the Roche Group,” said Jeff Marrazzo, chief executive officer and co-founder, of Spark Therapeutics.
WebFeb 25, 2024 · Jeff Marrazzo’s Big, Bold Philly Gene Therapy Vision The self-described science novice led Spark Therapeutics from start-up obscurity to the pinnacle of medicine … l thyroxin 25 μgWebFeb 24, 2024 · Jeffrey D. Marrazzo, the co-founder of Spark Therapeutics, guided the company to the launch of the world’s first regulatory-approved gene therapy for genetic diseases and helmed the company’s merger with Swiss pharma giant Roche. Now, he is stepping down from his role as CEO. Ron Philip, Spark’s COO, will take over the role. jdm background hdWebDec 17, 2024 · Spark Therapeutics Announces Updated Phase 1/2 Study Results Supporting the Durability of Investigational Gene Therapy SPK-8011 in Patients With Hemophilia A Dec 12, 2024 Chroma Medicine Welcomes Spark Therapeutics Co-Founder and Former Founding CEO Jeff Marrazzo to Board of Directors Oct 4, 2024 Report incorrect company … jdm baby car seatsWebJeff Marrazzo, Spark Therapeutics Inc: Profile and Biography - Bloomberg Markets Live Now Bloomberg TV+ Business of Sports: America Rolls the Dice with Online Gambling … jdm baby clothesWebDec 11, 2024 · December 11, 2024. Jeffrey D. Marrazzo C00 G00 WG03. 39; co-founder and CEO, Spark Therapeutics, Inc.; led Spark’s transition from a Children’s Hospital of Philadelphia research center to a fully integrated public biotechnology company. Proudest professional accomplishment? Founding and building Spark Therapeutics into a global … jdm b20b p8r high compressionWebSep 27, 2024 · View Jeffrey Marrazzo's email address (j*****@spark***.com) and phone number. Jeffrey works at Spark Therapeutics, Inc. as Chief Executive Officer and Co … l thyroxin 50 plus henning pznWebJeff Marrazzo Co-founder and Former Founding CEO and Board Member, Spark Therapeutics Jeff founded and built Spark Therapeutics into the world’s first fully … jdm bathrooms waukesha